158 related articles for article (PubMed ID: 33668370)
1. Targeted Plasma Metabolic Profiles and Risk of Recurrence in Stage II and III Colorectal Cancer Patients: Results from an International Cohort Consortium.
Ose J; Gigic B; Brezina S; Lin T; Baierl A; Geijsen AJMR; van Roekel E; Robinot N; Gicquiau A; Achaintre D; Keski-Rahkonen P; Duijnhoven FJBV; Gumpenberger T; Holowatyj AN; Kok DE; Koole A; Schrotz-King P; Ulrich AB; Schneider M; Ulvik A; Ueland PM; Weijenberg MP; Habermann N; Scalbert A; Gsur A; M Ulrich C
Metabolites; 2021 Feb; 11(3):. PubMed ID: 33668370
[TBL] [Abstract][Full Text] [Related]
2. Higher Plasma Creatinine Is Associated with an Increased Risk of Death in Patients with Non-Metastatic Rectal but Not Colon Cancer: Results from an International Cohort Consortium.
Ose J; Gigic B; Brezina S; Lin T; Peoples AR; Schobert PP; Baierl A; van Roekel E; Robinot N; Gicquiau A; Achaintre D; Scalbert A; van Duijnhoven FJB; Holowatyj AN; Gumpenberger T; Schrotz-King P; Ulrich AB; Ulvik A; Ueland PM; Weijenberg MP; Habermann N; Keski-Rahkonen P; Gsur A; Kok DE; Ulrich CM
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444500
[TBL] [Abstract][Full Text] [Related]
3. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study.
Bull CJ; Bell JA; Murphy N; Sanderson E; Davey Smith G; Timpson NJ; Banbury BL; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Burnett-Hartman A; Casey G; Castellví-Bel S; Chan AT; Chang-Claude J; Cross AJ; de la Chapelle A; Figueiredo JC; Gallinger SJ; Gapstur SM; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Joshu CE; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; May AM; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Phipps AI; Platz EA; Potter JD; Qu C; Quirós JR; Rennert G; Riboli E; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Tsilidis KK; Ulrich CM; van Duijnhoven FJB; van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Wang H; White E; Wolk A; Woods MO; Wu AH; Campbell PT; Zheng W; Peters U; Vincent EE; Gunter MJ
BMC Med; 2020 Dec; 18(1):396. PubMed ID: 33327948
[TBL] [Abstract][Full Text] [Related]
4. Plasma metabolites associated with colorectal cancer stage: Findings from an international consortium.
Geijsen AJMR; van Roekel EH; van Duijnhoven FJB; Achaintre D; Bachleitner-Hofmann T; Baierl A; Bergmann MM; Boehm J; Bours MJL; Brenner H; Breukink SO; Brezina S; Chang-Claude J; Herpel E; de Wilt JHW; Gicquiau A; Gigic B; Gumpenberger T; Hansson BME; Hoffmeister M; Holowatyj AN; Karner-Hanusch J; Keski-Rahkonen P; Keulen ETP; Koole JL; Leeb G; Ose J; Schirmacher P; Schneider MA; Schrotz-King P; Stift A; Ulvik A; Vogelaar FJ; Wesselink E; van Zutphen M; Gsur A; Habermann N; Kampman E; Scalbert A; Ueland PM; Ulrich AB; Ulrich CM; Weijenberg MP; Kok DE
Int J Cancer; 2020 Jun; 146(12):3256-3266. PubMed ID: 31495913
[TBL] [Abstract][Full Text] [Related]
5. Plasma metabolomic differences in early-onset compared to average-onset colorectal cancer.
Jayakrishnan T; Mariam A; Farha N; Rotroff DM; Aucejo F; Barot SV; Conces M; Nair KG; Krishnamurthi SS; Schmit SL; Liska D; Khorana AA; Kamath SD
Sci Rep; 2024 Feb; 14(1):4294. PubMed ID: 38383634
[TBL] [Abstract][Full Text] [Related]
6. A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.
Chen PC; Yeh YM; Lin BW; Chan RH; Su PF; Liu YC; Lee CT; Chen SH; Lin PC
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203549
[TBL] [Abstract][Full Text] [Related]
7. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
[No Abstract] [Full Text] [Related]
8. Metabolomic Pathway Activity with Genomic Single-Nucleotide Polymorphisms Associated with Colorectal Cancer Recurrence and 5-Year Overall Survival.
Fleming CA; Mohan HM; O'Leary DP; Corrigan M; Redmond HP
J Gastrointest Cancer; 2023 Mar; 54(1):247-258. PubMed ID: 35239102
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal Cancer: A Nationwide Danish Cohort Study.
Nors J; Iversen LH; Erichsen R; Gotschalck KA; Andersen CL
JAMA Oncol; 2024 Jan; 10(1):54-62. PubMed ID: 37971197
[TBL] [Abstract][Full Text] [Related]
10. Lifestyle after colorectal cancer diagnosis in relation to recurrence and all-cause mortality.
van Zutphen M; Boshuizen HC; Kenkhuis MF; Wesselink E; Geijsen AJMR; de Wilt JHW; van Halteren HK; Spillenaar Bilgen EJ; Keulen ETP; Janssen-Heijnen MLG; Breukink SO; Bours MJL; Kok DE; Winkels RM; Weijenberg MP; Kampman E; van Duijnhoven FJB
Am J Clin Nutr; 2021 Jun; 113(6):1447-1457. PubMed ID: 33677488
[TBL] [Abstract][Full Text] [Related]
11. Higher vitamin B6 status is associated with improved survival among patients with stage I-III colorectal cancer.
Holowatyj AN; Ose J; Gigic B; Lin T; Ulvik A; Geijsen AJMR; Brezina S; Kiblawi R; van Roekel EH; Baierl A; Böhm J; Bours MJL; Brenner H; Breukink SO; Chang-Claude J; de Wilt JHW; Grady WM; Grünberger T; Gumpenberger T; Herpel E; Hoffmeister M; Keulen ETP; Kok DE; Koole JL; Kosma K; Kouwenhoven EA; Kvalheim G; Li CI; Schirmacher P; Schrotz-King P; Singer MC; van Duijnhoven FJB; van Halteren HK; Vickers K; Vogelaar FJ; Warby CA; Wesselink E; Ueland PM; Ulrich AB; Schneider M; Habermann N; Kampman E; Weijenberg MP; Gsur A; Ulrich CM
Am J Clin Nutr; 2022 Aug; 116(2):303-313. PubMed ID: 35394006
[TBL] [Abstract][Full Text] [Related]
12. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
[TBL] [Abstract][Full Text] [Related]
13. Identifying metabolic features of colorectal cancer liability using Mendelian randomization.
Bull C; Hazelwood E; Bell JA; Tan V; Constantinescu AE; Borges C; Legge D; Burrows K; Huyghe JR; Brenner H; Castellvi-Bel S; Chan AT; Kweon SS; Le Marchand L; Li L; Cheng I; Pai RK; Figueiredo JC; Murphy N; Gunter MJ; Timpson NJ; Vincent EE
Elife; 2023 Dec; 12():. PubMed ID: 38127078
[TBL] [Abstract][Full Text] [Related]
14. Global and targeted serum metabolic profiling of colorectal cancer progression.
Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
[TBL] [Abstract][Full Text] [Related]
15.
Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics analyses of cancer tissue from patients with colorectal cancer.
Kang C; Zhang J; Xue M; Li X; Ding D; Wang Y; Jiang S; Chu FF; Gao Q; Zhang M
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772396
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS).
Benhaim L; Bouché O; Normand C; Didelot A; Mulot C; Le Corre D; Garrigou S; Djadi-Prat J; Wang-Renault SF; Perez-Toralla K; Pekin D; Poulet G; Landi B; Taieb J; Selvy M; Emile JF; Lecomte T; Blons H; Chatellier G; Link DR; Taly V; Laurent-Puig P
Eur J Cancer; 2021 Dec; 159():24-33. PubMed ID: 34731746
[TBL] [Abstract][Full Text] [Related]
18. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool.
Brown DG; Rao S; Weir TL; O'Malia J; Bazan M; Brown RJ; Ryan EP
Cancer Metab; 2016; 4():11. PubMed ID: 27275383
[TBL] [Abstract][Full Text] [Related]
20. Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare).
Liesenfeld DB; Habermann N; Toth R; Owen RW; Frei E; Staffa J; Schrotz-King P; Klika KD; Ulrich CM
Metabolomics; 2015 Aug; 11(4):998-1012. PubMed ID: 29250455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
